FDA PDUFA review goal date of March 27, 2025 for CARDAMYST™ (etripamil) nasal spray for Paroxysmal Supraventricular Tachycardia (PSVT)Assuming ...

that evaluated CARDAMYST in PSVT and proposed for the package insert ... the lives of people living with complex and life-altering heart conditions. The Company’s focus on understanding unmet ...

It is a common type of what's called paroxysmal supraventricular tachycardia (PSVT), a cardiac arrhythmia that often affects younger adults resulting in symptoms of dizziness or trouble breathing. The ...

An Australian man lived for 100 days with an artificial titanium heart while he awaited a donor transplant, the longest period to date of someone with the technology. The patient, a man in his 40s ...

It is a novel calcium channel blocker nasal spray under clinical development for frequent and often highly symptomatic episodes of PSVT and AFib ... and life-altering heart conditions.

Deciding when to go to the hospital for a rapid heart depends on your health history and how you are feeling overall. A heart rate of 100 beats per minute (bpm) or higher, also known as tachycardia, ...

It is a novel calcium channel blocker nasal spray under clinical development for frequent and often highly symptomatic episodes of PSVT and AFib-RVR. It is designed as a self-administered ... to ...

It is a novel calcium channel blocker nasal spray under clinical development for frequent and often highly symptomatic episodes of PSVT and AFib-RVR. It is designed as a self-administered ... to ...

It is a novel calcium channel blocker nasal spray under clinical development for frequent and often highly symptomatic episodes of PSVT and AFib-RVR. It is designed as a self-administered ... to ...

It is a common type of what's called paroxysmal supraventricular tachycardia (PSVT), a cardiac arrhythmia ... condition can occur in the context of heart disease. Causes may include a genetic ...